Chenshi Lin
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- Pulmonary Hypertension Research and Treatments 3
- Respiratory Support and Mechanisms 1
- Co-authors
- Wei He (7 shared papers)Chao Teng (6 shared papers)Marwa A. Sallam (1 shared paper)Qingqing Xiao (1 shared paper)Min Qiu (1 shared paper)Makhloufi Zoulikha (1 shared paper)Qiaobing Xu (1 shared paper)Xiaotong Li (1 shared paper)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Advanced Drug Delivery Reviews (1 paper)Molecular Metabolism (1 paper)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chenshi Lin
16 papers receiving 671 citations
Chenshi Lin's Hit Papers
Peers
Comparison fields: 5 of 88
- Biomaterials 249
- Pharmaceutical Science 37
- Biomedical Engineering 215
- Endocrinology, Diabetes and Metabolism 55
- Molecular Biology 234
Countries citing papers authored by Chenshi Lin
This map shows the geographic impact of Chenshi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenshi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenshi Lin more than expected).
Fields of papers citing papers by Chenshi Lin
This network shows the impact of papers produced by Chenshi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenshi Lin. The network helps show where Chenshi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenshi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 215 | |
| 2 | The effects of protein corona on in vivo fate of nanocarriers Hit paper breakdown → | 2022 | 201 |
| 3 | 2023 | 73 | |
| 4 | 2020 | 48 | |
| 5 | 2021 | 40 | |
| 6 | 2022 | 29 | |
| 7 | 2019 | 22 | |
| 8 | 2021 | 19 | |
| 9 | 2023 | 8 | |
| 10 | 2025 | 8 | |
| 11 | 2025 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2014 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2026 | 1 | |
| 18 | 2022 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Chenshi Lin
Chenshi Lin is a scholar working on Biomaterials, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Immunology and Cancer Research, having authored 21 papers that have together received 674 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Pulmonary Hypertension Research and Treatments (3 papers), Nanoplatforms for cancer theranostics (2 papers), MicroRNA in disease regulation (2 papers), Respiratory Support and Mechanisms (1 paper), Cancer Research and Treatments (1 paper), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Biomaterials (249 citations), Pharmaceutical Science (37 citations), Biomedical Engineering (215 citations), Endocrinology, Diabetes and Metabolism (55 citations) and Molecular Biology (234 citations). Chenshi Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei He, Chao Teng, Marwa A. Sallam, Qingqing Xiao, Min Qiu, Makhloufi Zoulikha, Qiaobing Xu, Xiaotong Li, Lifang Yin and Chao Qin. Their work appears in journals such as Acta Pharmaceutica Sinica B, Nanomedicine Nanotechnology Biology and Medicine, Advanced Drug Delivery Reviews, Molecular Metabolism and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.